Draftfcb Healthcare London appoints industry veterans
pharmafile | October 22, 2010 | News story | Medical Communications | Draftfcb, Draftfcb Healthcare, Jeff Daniels, Peter Hudspeth, medical communications
Draftfcb London has appointed Jeff Daniels and Peter Hudspeth as joint managing directors of its healthcare arm.
“I’m excited to have two such accomplished and talented industry veterans joining our team,” said Draftfcb London president Kate Howe. “We will be able to offer our clients a broader perspective on health, which continues to grow in importance and opportunity.”
Daniels and Hudspeth both come to the agency from LEC\TBWA\WorldHealth.
Daniels served as creative director at the agency for the past three years and his career spans nearly 30 years, during which time he worked on major healthcare brands including Crestor (Astrazeneca) and Singulair (Merck), and at such agencies as Grey Healthcare Group, PAN Communications and Publitek.
Hudspeth was client services director at LEC\TBWA\WorldHealth, having previously worked at Euro RSCG Healthcare and, prior to that, on the client side of the business at Searle Pharmaceuticals.
He has over 30 years of experience in the pharmaceutical industry, having handled large ethical brands such as Aricept (Eisai/Pfizer), Keppra (UCB) and Symbicort (AstraZeneca).
“The Draftfcb Healthcare network has garnered an enviable reputation as the ‘hottest’ of all the global healthcare networks. It is, therefore, an honour and a privilege to be jointly entrusted with further developing the network’s prestigious London office and enhancing the agency’s UK and pan-European capabilities,” said Daniels and Hudspeth.
The two will be tasked with providing cross-border specialist healthcare expertise, with the London agency now also serving as the UK and European hub for the Draftfcb Healthcare network.
Daniels and Hudspeth will also work together with the wider London agency to provide clients with a broader view on health and a diversified, integrated offering.
“I’m confident that two leading industry experts such as Jeff and Peter will bring a wealth of expertise to the Draftfcb Healthcare division, helping to grow the network within the UK and Europe,” said Draftfcb’s chief executive and president Dana Maiman. “They will also play an important role in our worldwide network.”
Draftfcb Healthcare has been recently growing quickly, having doubled in size over the past four years and won more than 16 new pieces of business and 19 awards in 2009.
The agency is part of Draftfcb, itself a member of the Interpublic Group, and its client roster includes Gilead, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, J&J, Medtronic and Merck.
Dominic Tyer
Related Content
Synergy Vision MD appointed as trustee of the Cystic Fibrosis Trust
Managing director of Synergy Vision Ffyona Dawber has been appointed to the Cystic Fibrosis Trust’s …
The mutual benefit of becoming one of Britain’s best workplaces
Imagine a company with a 100%-satisfied workforce. What could a team of such fulfilled employees …
